"renal cell cancer" trang 7 - tải miễn phí từ tailieunhanh
Intratumoural renal cell carcinoma haemorrhage following stereotactic radiotherapy: A case report

Intratumoural renal cell carcinoma haemorrhage following stereotactic radiotherapy: A case report
5    50    0
Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: A multi-center, retrospective cohort study

Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: A multi-center, retrospective cohort study
11    67    0
Pazopanib has equivalent anti-tumor effectiveness and lower Total costs than Sunitinib for treating metastatic or advanced renal cell carcinoma: A metaanalysis

Pazopanib has equivalent anti-tumor effectiveness and lower Total costs than Sunitinib for treating metastatic or advanced renal cell carcinoma: A metaanalysis
12    62    0
Collagen organization of renal cell carcinoma differs between low and high grade tumors

Collagen organization of renal cell carcinoma differs between low and high grade tumors
8    73    0
Real-world treatment patterns and adverse events in metastatic renal cell carcinoma from a large US claims database

Real-world treatment patterns and adverse events in metastatic renal cell carcinoma from a large US claims database
15    74    0
Pathologic analysis of non-neoplastic parenchyma in renal cell carcinoma: A comprehensive observation in radical nephrectomy specimens

Pathologic analysis of non-neoplastic parenchyma in renal cell carcinoma: A comprehensive observation in radical nephrectomy specimens
7    86    1
Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: Data from a national registry

Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: Data from a national registry
8    57    1
Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy

Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy
7    36    1
Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: A systematic study of 19 immunohistochemical markers in 42 cases

Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: A systematic study of 19 immunohistochemical markers in 42 cases
8    47    1
Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: A retrospective study

Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: A retrospective study
8    43    1
Scar site metastasis of renal cell carcinoma diagnosed on-site cytology: A case report

Scar site metastasis of renal cell carcinoma diagnosed on-site cytology: A case report
4    23    1
Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma

Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma
9    71    1
Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal

Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal
15    42    1
Axitinib, cabozantinib, or everolimus in the treatment of prior sunitinib-treated patients with metastatic renal cell carcinoma: Results of matching-adjusted indirect comparison analyses

Axitinib, cabozantinib, or everolimus in the treatment of prior sunitinib-treated patients with metastatic renal cell carcinoma: Results of matching-adjusted indirect comparison analyses
12    76    1
Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: Analysis from a randomised, double-blind phase II study

Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: Analysis from a randomised, double-blind phase II study
11    50    1
Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma

Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma
12    62    1
Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: A systematic review and meta-analysis

Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: A systematic review and meta-analysis
9    36    1
Early assessment with 18F-2-fluoro-2- deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab

Early assessment with 18F-2-fluoro-2- deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab
9    68    1
Tumor necrosis as a prognostic variable for the clinical outcome in patients with renal cell carcinoma: A systematic review and meta-analysis

Tumor necrosis as a prognostic variable for the clinical outcome in patients with renal cell carcinoma: A systematic review and meta-analysis
13    36    1
Metastatic polyp of the gallbladder from renal cell carcinoma

Metastatic polyp of the gallbladder from renal cell carcinoma
7    39    1